Heparin plus alteplase reduced morbidity more than heparin alone in submassive pulmonary embolism

Douketis, James
March 2003
ACP Journal Club;Mar/Apr2003, Vol. 138 Issue 2, p35
Academic Journal
Compares the application of heparin with alteplase and heparin alone in patients with acute submassive pulmonary embolism (PE) in Germany. Information on the patients included in the study; Role of thrombolysis in patients with PE; Outcomes of the study.


Related Articles

  • For pulmonary embolism, the edge goes to unfractionated heparin. Leibovitch, Eric // Modern Medicine;Apr98, Vol. 66 Issue 4, p65 

    Presents abstracts of studies regarding comparison of low-molecular-weight heparins with unfractionated heparin in the treatment of acute pulmonary embolism.

  • Fondaparinux in Pulmonary Embolism. Wertz, James // New England Journal of Medicine;2/5/2004, Vol. 350 Issue 6, p619 

    A letter to the editor is presented in response to the article "Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism," published in the October 30, 2003 issue.

  • Heparin plus Alteplase Compared with Heparin Alone in Patients with Submassive Pulmonary Embolism. Konstantinides, Stavros; Geibel, Annette; Heusel, Gerhard; Heinrich, Fritz; Kasper, Wolfgang // New England Journal of Medicine;10/10/2002, Vol. 347 Issue 15, p1143 

    Background: The use of thrombolytic agents in the treatment of hemodynamically stable patients with acute submassive pulmonary embolism remains controversial. Methods: We conducted a study of patients with acute pulmonary embolism and pulmonary hypertension or right ventricular dysfunction but...

  • Treatment of Pulmonary Embolism. Quinlan, D. J.; McQuillan, A.; Eikelboom, J. W. // Annals of Internal Medicine;2/3/2004, Vol. 140 Issue 3, pI43 

    Presents a study on the treatment of pulmonary embolism. Description of deep venous thrombosis; Definition of pulmonary embolism as clot in the lungs; Highlights of unfractionated heparin (UFH), a blood thinning drug; Significance of low-molecular-weight heparin (LMWH); Details of the study;...

  • Systematic review and meta-analysis for thrombolysis treatment in patients with acute submassive pulmonary embolism. Yaoqian Cao; Haiyan Zhao; Wanpeng Gao; Yan Wang; Jie Cao // Patient Preference & Adherence;2014, Vol. 8, p275 

    Purpose: The aim of this systematic review was to evaluate the efficacy and safety of thrombolytic treatment in patients with submassive pulmonary embolism (PE). Methods: An electronic search was carried out based on the databases from MEDLINE, Embase, Science Citation Index (SCI), and the...

  • Update on Pharmacologic Therapy for Pulmonary Embolism. Harikrishnan, Prakash; Palaniswamy, Chandrasekar; Aronow, Wilbert S. // Journal of Cardiovascular Pharmacology & Therapeutics;Mar2014, Vol. 19 Issue 2, p159 

    Warfarin, unfractionated heparin (UFH), and low-molecular-weight heparins are anticoagulants that have been used for treatment of pulmonary embolism. Currently approved drugs for treatment of venous thromboembolism include UFH, enoxaparin, dalteparin, fondaparinux, warfarin, and rivaroxaban. The...

  • Thromboprophylaxis with dalteparin in medical patients: which patients benefit? Cohen, Alexander T.; Turpie, Alexander G. G.; Leizorovicz, Alain; Olsson, Carl-Gustav; Vaitkus, Paul T.; Goldhaber, Samuel Z. // Vascular Medicine;2007, Vol. 12 Issue 2, p123 

    It is unclear whether thromboprophylaxis produces a consistent risk reduction in different subgroups of medical patients at risk from venous thromboembolism. We performed a retrospective, post hoc analysis of 3706 patients enrolled in the PREVENT study. Patients were at least 40 years old with...

  • LMW heparin effective for pulmonary embolus.  // BMJ: British Medical Journal (International Edition);5/8/2004, Vol. 328 Issue 7448, p1084 

    Presents a medical study to evaluate whether low molecular weight heparin is as effective as adjusted dose heparin in treating pulmonary embolism. Synopsis of the study; Conclusion that low molecular weight heparin is as effective as adjusted dose, unfractionated heparin in treating symptomatic...

  • Filter Placement for Duplicated Cava. Malgor, Rafael D.; Oropallo, Alisha; Wood, Emily; Natan, Kristina; Labropoulos, Nicos // Vascular & Endovascular Surgery;04/01/2011, Vol. 45 Issue 3, p269 

    Anatomic variations of the inferior vena cava (IVC) are found in 3-5% of the population. IVC duplication is a well-known anatomic variation that is important when relevant procedures are being planed. Therefore, the identification of IVC anomalies should be checked prior to pertinent...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics